GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (TSE:4875) » Definitions » Common Stock

MediciNova (TSE:4875) Common Stock : 円7.3 Mil (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is MediciNova Common Stock?

MediciNova's quarterly common stock declined from Sep. 2023 (円7.2 Mil) to Dec. 2023 (円7.1 Mil) but then increased from Dec. 2023 (円7.1 Mil) to Mar. 2024 (円7.3 Mil).

MediciNova's annual common stock increased from Dec. 2021 (円5.6 Mil) to Dec. 2022 (円6.6 Mil) and increased from Dec. 2022 (円6.6 Mil) to Dec. 2023 (円7.1 Mil).


MediciNova Common Stock Historical Data

The historical data trend for MediciNova's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Common Stock Chart

MediciNova Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.80 4.67 5.58 6.61 7.06

MediciNova Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.55 6.93 7.24 7.06 7.34

MediciNova Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


MediciNova (TSE:4875) Business Description

Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova (TSE:4875) Headlines

No Headlines